CG-100 Intraluminal Bypass Device

DEVICE3 trials

Sponsors

Colospan Ltd.

Conditions

Colorectal CancerColorectal SurgeryRectal CancerRectal TumorRectal/Anal

Unknown Phase

Safety and Performance of the CG-100 in Patients Undergoing Colorectal Surgery.

CompletedNCT03423485

Colospan Ltd.Colorectal Surgery

Start: 2018-01-01End: 2018-12-15Updated: 2026-07-06

Efficacy and Safety of the CG-100 Intraluminal Bypass Device

RecruitingNCT04184973

Colospan Ltd.Rectal/Anal, Rectal Cancer, Rectal Tumor

Start: 2020-06-23End: 2026-12-31Target: 250Updated: 2026-07-06

Evaluation of CG-100 Intraluminal Bypass Device

CompletedNCT05632744

Colospan Ltd.Colorectal Cancer

Start: 2023-03-15End: 2024-04-15Updated: 2026-07-02